These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 12958692
1. The interaction between Sillence type and BMD in osteogenesis imperfecta. Kok DJ, Uiterwaal CS, Van Dongen AJ, Kramer PP, Pruijs HE, Engelbert RH, Verbout AJ, Schweitzer DH, Sakkers RJ. Calcif Tissue Int; 2003 Nov; 73(5):441-5. PubMed ID: 12958692 [Abstract] [Full Text] [Related]
2. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate. Lindahl K, Kindmark A, Rubin CJ, Malmgren B, Grigelioniene G, Söderhäll S, Ljunggren Ö, Åström E. Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348 [Abstract] [Full Text] [Related]
3. Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment. Land C, Rauch F, Munns CF, Sahebjam S, Glorieux FH. Bone; 2006 Oct; 39(4):901-6. PubMed ID: 16730480 [Abstract] [Full Text] [Related]
4. Correlation of scoliotic curvature with Z-score bone mineral density and body mass index in patients with osteogenesis imperfecta. Watanabe G, Kawaguchi S, Matsuyama T, Yamashita T. Spine (Phila Pa 1976); 2007 Aug 01; 32(17):E488-94. PubMed ID: 17762282 [Abstract] [Full Text] [Related]
8. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. Letocha AD, Cintas HL, Troendle JF, Reynolds JC, Cann CE, Chernoff EJ, Hill SC, Gerber LH, Marini JC. J Bone Miner Res; 2005 Jun 01; 20(6):977-86. PubMed ID: 15883638 [Abstract] [Full Text] [Related]
10. Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta. Kocijan R, Muschitz C, Fratzl-Zelman N, Haschka J, Dimai HP, Trubrich A, Bittighofer C, Resch H. Skeletal Radiol; 2013 Feb 01; 42(2):187-94. PubMed ID: 22955449 [Abstract] [Full Text] [Related]
11. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. J Bone Miner Res; 2002 Jan 01; 17(1):30-8. PubMed ID: 11771667 [Abstract] [Full Text] [Related]
12. Development of scoliosis in young children with osteogenesis imperfecta undergoing intravenous bisphosphonate therapy. Kashii M, Kanayama S, Kitaoka T, Makino T, Kaito T, Iwasaki M, Kubota T, Yamamoto T, Ozono K, Yoshikawa H. J Bone Miner Metab; 2019 May 01; 37(3):545-553. PubMed ID: 30187275 [Abstract] [Full Text] [Related]
13. Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. Munns CF, Rauch F, Travers R, Glorieux FH. J Bone Miner Res; 2005 Jul 01; 20(7):1235-43. PubMed ID: 15940378 [Abstract] [Full Text] [Related]
14. A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype. Sarathchandra P, Pope FM, Kayser MV, Ali SY. J Pathol; 2000 Nov 01; 192(3):385-95. PubMed ID: 11054723 [Abstract] [Full Text] [Related]